Literature DB >> 2016792

Priapism in hypogonadal men receiving gonadotropin releasing hormone.

R K Whalen1, R W Whitcomb, W F Crowley, F J McGovern.   

Abstract

To our knowledge we report the first 2 cases of priapism occurring in hypogonadal men receiving gonadotropin releasing hormone therapy. Hypogonadal patients receiving hormonal therapy should be informed about the possibility of priapism and the importance of early urological consultation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016792     DOI: 10.1016/s0022-5347(17)38530-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

Review 1.  Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it?

Authors:  R Scaletscky; J A Smith
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 2.  The etiology, diagnosis, and treatment of priapism: review of the American Foundation for Urologic Disease Consensus Panel Report.

Authors:  Hossein Sadeghi-Nejad; Alan D Seftel
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 3.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.